首页> Oncotarget> miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS.

miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS.

导出 OA

翻译打印收藏纠错

第一作者： Danilo,Fiore

第一单位： Department of Molecular Medicine and Medical Biotechnology, "Federico II" University of Naples, Naples, Italy.

作者： Danilo,Fiore ^[1] ; Elvira,Donnarumma ^[2] ; Giuseppina,Roscigno ^[3] ; Margherita,Iaboni ^[1] ; Valentina,Russo ^[1] ; Alessandra,Affinito ^[1] ; Assunta,Adamo ^[1] ; Fabio,De Martino ^[1] ; Cristina,Quintavalle ^[4] ; Giulia,Romano ^[5] ; Adelaide,Greco ^[6] ; Ylermi,Soini ^[7] ; Arturo,Brunetti ^[6] ; Carlo M,Croce ^[5] ; Gerolama,Condorelli ^[3]

作者单位： Department of Molecular Medicine and Medical Biotechnology, "Federico II" University of Naples, Naples, Italy. ^[1] IRCCS-SDN, Naples, Italy. ^[2] Department of Molecular Medicine and Medical Biotechnology, "Federico II" University of Naples, Naples, Italy.;IEOS, CNR, Naples, Italy. ^[3] Institute of Pathology, Molecular Pathology Division, University of Basel, Basel, Switzerland. ^[4] Department of Molecular Virology, Immunology and Medical Genetics, Human Cancer Genetics Program, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA. ^[5] Department of Advanced Biomedical Science, University of Naples Federico II, Naples, Italy.;Ceinge, Biotecnologie Avanzate, Scarl, Naples, Italy. ^[6] Cancer Center of Eastern Finland, University of Eastern Finland, Kuopio, Finland. ^[7]

关键词 NRAS glioblastoma microRNAs signal-transduction survival